1. Home
  2. OLMA vs WEYS Comparison

OLMA vs WEYS Comparison

Compare OLMA & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • WEYS
  • Stock Information
  • Founded
  • OLMA 2006
  • WEYS 1906
  • Country
  • OLMA United States
  • WEYS United States
  • Employees
  • OLMA N/A
  • WEYS N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • OLMA Health Care
  • WEYS Consumer Staples
  • Exchange
  • OLMA Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • OLMA 299.7M
  • WEYS 303.5M
  • IPO Year
  • OLMA 2020
  • WEYS N/A
  • Fundamental
  • Price
  • OLMA $5.33
  • WEYS $28.50
  • Analyst Decision
  • OLMA Strong Buy
  • WEYS
  • Analyst Count
  • OLMA 4
  • WEYS 0
  • Target Price
  • OLMA $24.50
  • WEYS N/A
  • AVG Volume (30 Days)
  • OLMA 411.5K
  • WEYS 9.2K
  • Earning Date
  • OLMA 08-05-2025
  • WEYS 08-05-2025
  • Dividend Yield
  • OLMA N/A
  • WEYS 3.79%
  • EPS Growth
  • OLMA N/A
  • WEYS N/A
  • EPS
  • OLMA N/A
  • WEYS 3.04
  • Revenue
  • OLMA N/A
  • WEYS $286,762,000.00
  • Revenue This Year
  • OLMA N/A
  • WEYS N/A
  • Revenue Next Year
  • OLMA N/A
  • WEYS N/A
  • P/E Ratio
  • OLMA N/A
  • WEYS $9.57
  • Revenue Growth
  • OLMA N/A
  • WEYS N/A
  • 52 Week Low
  • OLMA $2.86
  • WEYS $25.51
  • 52 Week High
  • OLMA $16.62
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.85
  • WEYS 29.46
  • Support Level
  • OLMA $4.40
  • WEYS $31.40
  • Resistance Level
  • OLMA $5.36
  • WEYS $32.05
  • Average True Range (ATR)
  • OLMA 0.29
  • WEYS 0.89
  • MACD
  • OLMA 0.07
  • WEYS -0.44
  • Stochastic Oscillator
  • OLMA 93.20
  • WEYS 4.36

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: